Taysha Gene Therapies, Inc.

The current price of TSHA is 2.45 USD — it has decreased by 4.85% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Taysha Gene Therapies, Inc. stocks are traded under the ticker TSHA.

Taysha Gene Therapies, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for Taysha Gene Therapies, Inc. has a max estimate of 9.00 USD and a min estimate of 2.00 USD.

TSHA earnings for the last quarter are −0.93 USD whereas the estimation was −0.17 USD which accounts for −438.65% surprise. Estimated earnings for the next quarter are −0.11 USD. See more details about Taysha Gene Therapies, Inc. earnings.

Yes, you can track Taysha Gene Therapies, Inc. financials in yearly and quarterly reports right on TradingView.

Like other stocks, TSHA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Taysha Gene Therapies, Inc. stock right from TradingView charts — choose your broker and connect to your account.

TSHA reached its all-time high on Jan 19, 2021 with the price of 33.35 USD, and its all-time low was 0.50 USD and was reached on Jun 26, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has 52.00 employees. See our rating of the largest employees — is Taysha Gene Therapies, Inc. on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Taysha Gene Therapies, Inc. EBITDA is ‪−69.34 M‬ USD, and current EBITDA margin is −453.06%. See more stats in Taysha Gene Therapies, Inc. financial statements.